AstraZeneca PLC (LSE:AZN) - Share price


Stock Report

AstraZeneca PLC AZN

Last Price
GBX7,272.00

Day Change
-44.00|-0.60%

As of 15/11/2019
13:35:51 GMT | GBX
Minimum 15 Minutes Delay.

Last Close7,316.00p
Day Range7,237.00 - 7,394.00
Mkt Cap95.98Bil
52-Wk Range109.51 - 8,227.88
Yield %2.96
ISINGB0009895292
Volume571,106
P/E59.17
P/S4.17
P/CF35.20

Share Price

Total Returns 14/11/2019

 Chg (%)  
More ...
AstraZeneca PLC4.83 
FTSE 100 TR GBP1.46
 
Financials
201620172018
More ...
Income Statement
Turnover23,002.0022,465.0022,090.00
Operating Profit3,572.002,052.001,510.00
Net Profit3,406.002,868.002,050.00
Reported EPS2.762.371.70
Balance Sheet
Current Assets13,262.0013,150.0014,609.00
Non Current Assets49,264.0050,204.0045,060.00
Total Assets62,526.0063,354.0060,651.00
Current Liabilities15,256.0016,383.0016,292.00
Total Liabilities---
Total Equity16,669.0016,642.0014,044.00
Cash Flow
Operating Cash Flow4,557.004,032.003,155.00
Net Change in Cash-1,148.00-1,686.001,537.00

Regulatory News

DateAuthor Headline
29/10/2019James Gard Brexit Investment Strategies for Uncertain Times
With a General Election slated for December and Brexit postponed until 2020, investors should consider how their portfolios are positioned for more months of uncertainty 
14/10/2019James Gard Top 20 FTSE Dividend Paying Stocks
UPDATED OCTOBER 2019: Imperial retains its top spot because its share price has weakened since the chief executive Alison Cooper announced her departure
24/07/2019James Gard Glaxo's Vaccines Division Outperforms
FTSE 100 dividend stalwart posts steady results in the first six months and expects better performance in the second half, during which the joint venture with Pfizer will complete
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
07/05/2019PurchaseMr. Marc Dunoyer5,800.008,500493,000.00
30/04/2019PurchasePhilip A J Broadley5,738.0052029,838.00
29/04/2019PurchaseMs. Sherilyn S. (Sheri) McCoy19.094,74490,559.00
29/04/2019PurchaseMs. Sherilyn S. (Sheri) McCoy19.092003,817.00

Company Profile

AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer, immunology, and neuroscience.

Sector

Drug Manufacturers - General

Index

FTSE 100 ,FTSE 350 ,FTSE All Share ,FTSE Eurotop 100 ,FTSE Eurotop 300

Next Event 14/02/2020

Final Results
Ratios
Comp
More ...
PER (E)60.29
Div Yld (E)2.92
PEG (E)1.54
ROCE6.29
Op Mrgn0.07
EPS Grwth-0.82
Dividends
PreviousLatest
More ...
Record Date01/03/1909/08/19
Ex-Div28/02/1908/08/19
Paid27/03/1909/09/19
Amnt146.8071.90
Directors
More ...
Non-Executive DirectorMs. Sherilyn S. (Sheri) McCoy
Non-Executive Director, ChairmanMr. Leif Johansson
Executive Director, Chief Financial OfficerMr. Marc Dunoyer
Non-Executive DirectorMr. Marcus Wallenberg
Executive Director, Chief Executive OfficerMr. Pascal Soriot
Non-Executive DirectorPhilip A J Broadley
Non-Executive DirectorMr. Graham Andrew Chipchase
Non-Executive DirectorProf Genevieve Berger
Non-Executive DirectorDeborah DiSanzo
Non-Executive DirectorProfessor Nazneen Rahman
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.